| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/16/2003 | EP0871483B1 Helper virus-free aav production |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | CN1411505A Membrane virus host range mutations and their uses as vaccine stroma |
| 04/16/2003 | CN1410541A Expression quantity of increasing insect rhabdovirus system exogenous gene by utilizing insect hormone |
| 04/16/2003 | CN1410540A Method of producing broad adaptability, high specific activity phytase and acidic phosphoesterase using silkworm bioreactor |
| 04/16/2003 | CN1410535A Mandarin fish rhabdo virus toxic strain, its preparation method and application |
| 04/16/2003 | CN1410534A Lefteye flounder lymph tumour virus toxic strain, its preparation method and application |
| 04/16/2003 | CN1410533A Large brill rhabdo virus toxic strain and its preparation method and application |
| 04/15/2003 | US6548635 Protein or polypeptide that binds with an antibody that binds to a polypeptide of the specific amino acid sequence; for diagnosis and the preparation of vaccines |
| 04/15/2003 | US6548632 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548301 Expression vectors having a reduced content of viral genes, are safer because of expressing more nonviral nucleotide and much less immunogenic or toxic proteins; contain less than 400 bp of the nucleotide sequwence which codes for gag |
| 04/15/2003 | US6548295 Complex of lipo-viro-particles, method of preparation and applications |
| 04/15/2003 | US6548286 Methods for increasing the efficiency of recombinant AAV product |
| 04/15/2003 | US6548249 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548242 Process for the sterilization of biological compositions and the product thereby |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/10/2003 | WO2003029460A1 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 04/10/2003 | WO2003029448A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 04/10/2003 | WO2003029431A2 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 04/10/2003 | WO2003029416A2 Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof |
| 04/10/2003 | WO2003029412A2 Restricted expression lentivial vectors |
| 04/10/2003 | WO2003029409A2 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 04/10/2003 | WO2003029274A2 Paramyxoviruses as gene transfer vectors to lung cells |
| 04/10/2003 | WO2003028432A2 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 04/10/2003 | WO2003000855A3 Chimeric capsid proteins and uses thereof |
| 04/10/2003 | WO2002012477A3 Enhanced replication of hcv rna |
| 04/10/2003 | WO2001092547A9 Modified bovine adenovirus having altered tropism |
| 04/10/2003 | US20030068807 Precursor conversion screening methods |
| 04/10/2003 | US20030068334 IBDV strain for in ovo administration |
| 04/10/2003 | US20030068332 Replication-competent recombinant virus and methods of use thereof |
| 04/10/2003 | CA2462766A1 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 04/10/2003 | CA2462628A1 Restricted expression lentiviral vectors |
| 04/10/2003 | CA2461267A1 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 04/10/2003 | CA2459133A1 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 04/09/2003 | EP1300156A2 Otitis media vaccine |
| 04/09/2003 | EP1300082A2 Lysin of a bacteriophage of Clostridia spp |
| 04/09/2003 | EP1299556A2 Host cells containing multiple integrating vectors |
| 04/09/2003 | EP1299554A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 04/09/2003 | EP1299130A2 A method of treating and preventing infectious diseases |
| 04/09/2003 | EP0784685B1 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 04/09/2003 | CN1409765A Prevention of myocarditis, abortion and intrauterine infection associated with procine circovirus 2 |
| 04/09/2003 | CN1408851A Non-coding region and P.M gene sequence and vector construction of long-47 measles virus |
| 04/08/2003 | US6544948 ΔP62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 04/08/2003 | US6544928 Virus capable of specifically infecting, growing within, and lysing red tide plankton; a method and an agent for preventing red tide using the virus; a method for isolating the virus; and a method for subculturing the virus |
| 04/08/2003 | US6544785 Helper viruses; genetic engineering |
| 04/08/2003 | US6544780 Adenovirus vector with multiple expression cassettes |
| 04/08/2003 | US6544769 Compostions comprising viruses and methods for concentrating virus preparations |
| 04/08/2003 | US6544758 Methods for expressing endostatin protein |
| 04/08/2003 | US6544752 Anigenically-marked non-infectious retrovirus-like particles |
| 04/08/2003 | US6544731 Genetic engineering; binding antibodies |
| 04/08/2003 | US6544729 Bioluminescent biosensor device |
| 04/08/2003 | US6544728 Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2 |
| 04/08/2003 | US6544527 Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region |
| 04/08/2003 | US6544526 For immunization of horses |
| 04/08/2003 | US6544507 Anti-neoplastic viral agents |
| 04/08/2003 | CA2205015C Method for producing biologicals in protein-free culture |
| 04/08/2003 | CA2107732C Retrovirus from the hiv group and its use |
| 04/04/2003 | WO2002029063A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 04/04/2003 | CA2424877A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 04/03/2003 | WO2003027269A1 Chronic pathogen-expressing cell lines |
| 04/03/2003 | WO2003026767A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 04/03/2003 | WO2003026690A1 Incapacitated whole-cell immunogenic bacterial compositions |
| 04/03/2003 | WO2003026479A2 Methods of suppressing microglial activation |
| 04/03/2003 | WO2002088338A3 Method for replicating the hepatitis c virus |
| 04/03/2003 | WO2002072836A3 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 04/03/2003 | WO2002014526A3 Replication competent aav helper functions |
| 04/03/2003 | WO2002012524A3 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 04/03/2003 | US20030065158 Propagation of cattle respiratory syncytial virus; propagate cells, insert synthetic nucleotide sequences codiing phosphoprotein into cell, mutate transfered nucleotide sequences, monitor gene expression |
| 04/03/2003 | US20030064054 Detection of human immunodeficiency virus using cells transduced with a complex viral vector |
| 04/03/2003 | CA2461710A1 Incapacitated whole-cell immunogenic bacterial compositions |
| 04/03/2003 | CA2461305A1 Methods of suppressing microglial activation and systemic inflammatory responses |
| 04/02/2003 | EP1298211A2 Polynucleotide segment of HPV16 Genome |
| 04/02/2003 | EP1298139A2 Avian herpes virus-based recombinant infectious bursal disease vaccine |
| 04/02/2003 | EP1297110A1 Attenuated bovine respiratory syncytial virus |
| 04/02/2003 | EP1296710A1 Recombinant vaccines against infectious bursal disease virus |
| 04/02/2003 | EP0914460B1 Vehicle for the transport of molecular substances |
| 04/02/2003 | EP0774513B1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
| 04/02/2003 | EP0696326B1 Use of NDV in the manufacture of a medicament for treating cancer |
| 04/02/2003 | EP0677114B1 Recombinant swinepox virus |
| 04/02/2003 | EP0566732B1 Adeno-associated virus-2 basal vectors |
| 04/02/2003 | EP0561890B1 Dna expression systems based on alphaviruses |
| 04/02/2003 | CN1408022A Recombinant adenoviruses for sodium/iodide symporter (NIS) |
| 04/02/2003 | CN1408021A Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 04/02/2003 | CN1406631A Establishment of drug production system by non-virus bio-technology |
| 04/01/2003 | US6541258 AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectors |
| 04/01/2003 | US6541248 Genome comprising nucleotide sequence encoding an anti-sense RNA or ribozyme; cleavage of a second nucleotide sequence which encodes a polypeptide; use in gene therapy |
| 04/01/2003 | US6541229 Use for better preservation of red blood cells during storage and increased viability in vivo following transfusion |
| 04/01/2003 | US6541223 Propagating permissive eukaryotic cells, transiently stressing to increase production of protein, introducing virus stock, incubating, then harvesting viral agent; vaccines, diagnostic assay |
| 04/01/2003 | US6541210 Viruses; bacteriophage; Hepatitis B; Hepatitis C; autoimmune disease; use to immunize an organism with a peptide that mimics an antigen or pathogenic organism specific to a disease |
| 04/01/2003 | US6541010 Alphavirus RNA replicon systems |
| 04/01/2003 | US6541009 Viral vaccines |
| 04/01/2003 | US6541003 An immunizing formulation comprising a plasmid encoding an attenuated, doxycycline-inducible proviral molecular clone of the human immunodeficiency virus type 1, and a pharmaceutical carrier |
| 04/01/2003 | CA2290906C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 03/27/2003 | WO2003025570A1 Method of examining (-) strand rna virus vector having lowered ability to form grains and method of constructing the same |
| 03/27/2003 | WO2003025191A2 Pseudotyped retroviral vector system |
| 03/27/2003 | WO2003025190A1 Tumor-specific promoter and use thereof |
| 03/27/2003 | WO2003025161A1 Site-specific recombinase based method for producing adenoviral vectors |
| 03/27/2003 | WO2003024502A2 Compositions and methods useful for non-invasive delivery of therapeutic molecules to the bloodstream |
| 03/27/2003 | WO2003024481A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 03/27/2003 | WO2002068927A3 Using viruses to detect or purify proteins |